{ "cik": 1711754, "cik_padded": "0001711754", "entityName": "Inmune Bio, Inc.", "fiscal_years": [ { "accn": "0001213900-26-036370", "filed": "2026-03-30", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1042000.0, "cash": 24751000.0, "eps_diluted": -1.86, "free_cash_flow": -23624000.0, "net_income": -45933000.0, "operating_cash_flow": -22582000.0, "operating_income": -47383000.0, "revenue": 50000.0, "stockholders_equity": 23524000.0, "total_assets": 32351000.0, "total_liabilities": 8827000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3752338037748682, "revenue_growth_yoy": 2.5714285714285716, "roa_avg2y": -1.2774602644862543, "roa_period_end": -1.4198324626750332, "roe_avg2y": -1.651642365293684, "roe_period_end": -1.9526015983676246 } }, { "accn": "0001213900-26-036370", "filed": "2026-03-30", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 20922000.0, "eps_diluted": -2.11, "net_income": -42082000.0, "operating_cash_flow": -33361000.0, "operating_income": -42635000.0, "revenue": 14000.0, "stockholders_equity": 32097000.0, "total_assets": 39562000.0, "total_liabilities": 7465000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2325762532323893, "revenue_growth_yoy": -0.9096774193548387, "roa_avg2y": -0.8715967813758894, "roa_period_end": -1.0636974874879934, "roe_avg2y": -1.212091536212682, "roe_period_end": -1.3110882637006573 } }, { "accn": "0001213900-26-036370", "filed": "2026-03-30", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 35848000.0, "eps_diluted": -1.67, "net_income": -30008000.0, "operating_cash_flow": -11980000.0, "operating_income": -29741000.0, "revenue": 155000.0, "stockholders_equity": 37340000.0, "total_assets": 57001000.0, "total_liabilities": 18862000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5051419389394751, "revenue_growth_yoy": -0.5855614973262032, "roa_avg2y": -0.432404392057408, "roa_period_end": -0.526446904440273, "roe_avg2y": -0.6159024670580026, "roe_period_end": -0.8036422067487947 } }, { "accn": "0001213900-24-027206", "filed": "2025-03-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 52153000.0, "eps_diluted": -1.52, "net_income": -27299000.0, "operating_cash_flow": -22686000.0, "operating_income": -25951000.0, "revenue": 374000.0, "stockholders_equity": 60104000.0, "total_assets": 81795000.0, "total_liabilities": 21691000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3608911220551045, "revenue_growth_yoy": 1.0662983425414365, "roa_avg2y": -0.30041817981732144, "roa_period_end": -0.33374900666299895, "roe_avg2y": -0.38907139650393, "roe_period_end": -0.4541960601623852 } }, { "accn": "0001213900-24-027206", "filed": "2024-03-28", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 74810000.0, "eps_diluted": -1.88, "net_income": -30340000.0, "operating_cash_flow": -28504000.0, "operating_income": -29153000.0, "revenue": 181000.0, "stockholders_equity": 80225000.0, "total_assets": 99945000.0, "total_liabilities": 19720000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.245808663134933, "revenue_growth_yoy": 15.454545454545455, "roa_avg2y": -0.4315758778387067, "roa_period_end": -0.30356696182900594, "roe_avg2y": -0.5100059674396322, "roe_period_end": -0.37818635088812713 } }, { "accn": "0001213900-23-016875", "filed": "2023-03-02", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 21967000.0, "net_income": -12099000.0, "operating_cash_flow": -8943000.0, "operating_income": -12228000.0, "revenue": 11000.0, "stockholders_equity": 38754000.0, "total_assets": 40656000.0, "total_liabilities": 1902000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04907880476854002, "roa_avg2y": -0.37155484339427064, "roa_period_end": -0.2975944510035419, "roe_avg2y": -0.38801231479699827, "roe_period_end": -0.31220003096454557 } }, { "accn": "0001213900-22-010573", "filed": "2022-03-03", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 6996000.0, "net_income": -7678313.0, "operating_cash_flow": -5384656.0, "operating_income": -7756001.0, "stockholders_equity": 23610000.0, "total_assets": 24470321.0, "total_liabilities": 860543.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.03644824227022448, "roa_avg2y": -0.36708776852746555, "roa_period_end": -0.31378064063810196, "roe_avg2y": -0.3824853841544927, "roe_period_end": -0.3252144430326133 } }, { "accn": "0001213900-21-013456", "filed": "2021-03-04", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 186204.0, "net_income": -12440023.0, "operating_cash_flow": -2058994.0, "operating_income": -12440023.0, "stockholders_equity": 16539576.0, "total_assets": 17363342.0, "total_liabilities": 823766.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04980575076410665, "roa_avg2y": -0.6954237845451405, "roa_period_end": -0.7164532611291076, "roe_avg2y": -0.7181771128288509, "roe_period_end": -0.7521367536870351 } }, { "accn": "0001640334-19-000466", "filed": "2020-03-11", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 1370711.0, "net_income": -831486.0, "operating_cash_flow": -761834.0, "operating_income": -981480.0, "stockholders_equity": 18103753.0, "total_assets": 18413470.0, "total_liabilities": 309717.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.017107889176349235, "roa_period_end": -0.045156399092620786, "roe_avg2y": -0.09262120186805016, "roe_period_end": -0.04592892976390034 } }, { "accn": "0001640334-19-000466", "filed": "2019-03-29", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "stockholders_equity": "USD" }, "fundamentals": { "cash": 141659.0, "stockholders_equity": -149203.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001213900-26-036370", "filed": "2026-03-30", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001711754.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001711754.json" }, "ticker": "INMB" }